Adrenocorticotrophic hormone-induced hypertension in the rat: Effects of the endothelin antagonist bosentan

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 8, 1999, Pages 628-633

  Fraser, Tafline B ^a   Mangos, George J ^a   Turner, Steven W ^a   Whitworth, Judith A ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Adrenocorticotrophic hormone; Antagonist; Blood pressure; Bosentan; Endothelin; Experimental; Hypertension; Rats

Indexed keywords

BOSENTAN; CORTICOTROPIN; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HEART OUTPUT; HORMONAL REGULATION; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC REGULATION; NONHUMAN; PRESSOR RESPONSE; RAT; URINE VOLUME; VASCULAR RESISTANCE;

EID: 0032777210     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03101.x     Document Type: Article

References (28)

1. Whitworth JA, Hewitson TD, Ming L et al. Adrenocorticotrophin-induced hypertension in the rat: Haemodynamic, metabolic and morphological characteristics. J. Hypertens. 1990; 8: 27-36.
2. Whitworth JA, Hewitson TD, Cornwallis C. Corticotrophin effects on blood pressure and fluid and electrolyte homeostasis in five strains of rats. Am. J. Hypertens. 1992; 5: 302-13.
3. Scoggins BA, Denton DA, Whitworth JA, Coghlan JP. ACTH dependent hypertension. Clin. Exp. Hypertens. [A] 1984; A6: 599-646.
4. Whitworth JA, Connell JM, Lever AF, Fraser R. Pressor responsiveness in steroid-induced hypertension in man. Clin. Exp. Pharmacol. Physiol. 1986; 13: 353-8.
5. Turner SW, Wen C, Li M, Whitworth JA. L-arginine prevents corticotrophin-induced increases in blood pressure in the rat. Hypertension 1996; 27: 184-9.
6. Wen C, Fraser T, Li M, Whitworth JA. Hemodynamic profile of corticotrophin-induced hypertension in the rat. J. Hypertens. 1998; 16: 187-94.
7. Whitworth JA, Connell JM, Gordon D, Scoggins BA. Effects of indomethacin on steroid-induced changes in pressor responsiveness in man. Clin. Exp. Pharmacol. Physiol. 1988; 15: 305-10.
8. Schiffrin EL. Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension 1995; 25: 1135-43.
9. Bartholomeusz B, Hardy KJ, Nelson AS, Phillips PA. Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates. Hypertension 1996; 27: 1341-5.
10. Li JS, Lariviere R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension 1994; 24: 183-8.
11. Li JS, Schiffrin EL. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J. Hypertens. 1995; 13: 647-52.
12. Li JS, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995; 25: 495-500.
13. Li JS, Knafo L, Turgeon A, Garcia R, Schiffrin EL. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertension. Am. J. Physiol. 1996; 271: H88-93.
14. Lanese D, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J. Clin. Invest. 1993; 91: 2144-9.
15. Clozel M, Breu V, Gray GA et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 1994; 270: 228-35.
16. Clozel M, Breu V, Gray GA, Loffler BM. In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: Implications for endothelin physiology. J. Card. Pharmacol. 1993; 22 (Suppl. 8): S377-9.
17. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. New Eng. J.Med. 1998; 338: 784-90.
18. Phillips PA, Rolls KA, Burrell LM, Casley D, Aldred KL, Hardy KJ. Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertension. Clin. Exp. Pharmacol. Physiol. 1994; 21: 223-6.
19. Turner SW, Wen C, Li M, Fraser TB, Whitworth JA. Adrenocorticotrophin dose-response relationships in the rat: Haemodynamic, metabolic, and hormonal effects. J. Hypertens. 1998; 16: 593-600.
20. Cameron L, Kapas S, Hinson JP. Endothelin-1 release from the isolated perfused rat adrenal gland is elevated acutely in response to increasing flow rates and ACTH (1-24). Biochem. Biophys. Res. Commun. 1994; 202: 873-9.
21. May CN, Mathai ML, McDougall JG, Whitworth JA. Cardiovascular effects of long-term endothelin infusion and responses to endothelin during ACTH infusion in conscious sheep. Am. J. Hypertens. 1993; 6: 837-43.
22. Lariviere R, Sventek P, Thibault G, Schiffin EL. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. Can. J. Physiol. Pharmacol. 1995; 73: 390-8.
23. Lariviere R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993; 21: 294-300.
24. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am. J. Hypertens. 1991; 4: 303-8.
25. Doucet J, Gonzalez, W, Michel JB. Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency. J. Cardiol. Pharmacol. 1996; 27: 643-51.
26. Balakrishnan SM, Di Wang H, Gopalakrishnan V, Wilson TW, McNeill RJ. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 1996; 28: 806-9.
27. McDougall JG, Barnes AM, Coghlan JP et al. The effect of corticotrophin (ACTH) administration on the pressor action of angiotensin II, noradrenaline and tyramine in sheep. Clin. Exp. Pharmacol. Physiol. 1978; 5: 449-55.
28. Whitworth JA, Connell JM, Gordon D, Scoggins BA. Effects of indomethacin on steroid-induced changes in pressor responsiveness in man. Clin. Exp. Pharmacol. Physiol. 1988; 15: 305-10.